|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
ACUTE DYSTONIC REACTION WITH CONCOMITANT USE
|
DISULFIRAM CAUSES ACUTE PSYCHOSIS
|
ADDITIVE MYELOSUPPRESSION WHEN USED WITH OTHER MYELOSUPPRESSIVE DRUGS
|
ADDITIVE MYELOSUPPRESSION WHEN USED WITH OTHER MYELOSUPPRESSIVE DRUGS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
DISULFIRAM LIKE REACTION WITH ALCOHOL
|
DISULFIRAM LIKE REACTION WITH ALCOHOL
|
DISULFIRAM LIKE REACTION WITH ALCOHOL
|
DISULFIRAM LIKE REACTION WITH ALCOHOL
|
PHENOBARBITONE ENHANCES DRUG METABOLISM HENCE DECREASED SERUM LEVELS OF THE DRUG HAVE BEEN OBSERVED
|
PHENOBARBITONE ENHANCES DRUG METABOLISM HENCE DECREASED SERUM LEVELS OF THE DRUG HAVE BEEN OBSERVED
|
PHENOBARBITONE ENHANCES DRUG METABOLISM HENCE DECREASED SERUM LEVELS OF THE DRUG HAVE BEEN OBSERVED
|
PHENOBARBITONE ENHANCES DRUG METABOLISM HENCE DECREASED SERUM LEVELS OF THE DRUG HAVE BEEN OBSERVED
|
PHENOBARBITONE ENHANCES DRUG METABOLISM HENCE DECREASED SERUM LEVELS OF THE DRUG HAVE BEEN OBSERVED
|
PHENOBARBITONE ENHANCES DRUG METABOLISM HENCE DECREASED SERUM LEVELS OF THE DRUG HAVE BEEN OBSERVED
|
SECNIDAZOLE IMPAIRES METABOLISM OR INCREASE EXCRETION OF THE DRUG
|
SECNIDAZOLE IMPAIRES METABOLISM OR INCREASE EXCRETION OF THE DRUG
|
SECNIDAZOLE IMPAIRES METABOLISM OR INCREASE EXCRETION OF THE DRUG
|
SECNIDAZOLE IMPAIRES METABOLISM OR INCREASE EXCRETION OF THE DRUG
|
SECNIDAZOLE IMPAIRES METABOLISM OR INCREASE EXCRETION OF THE DRUG
|